FDA approves first oral microbiome therapy Vowst
EU publishes proposed drug laws overhaul, setting up tussle with industry
Lilly drug Mounjaro succeeds in second weight loss study
Sanofi, after $8B outlay, sees M&A strategy deliver 2 more duds
*please scroll down for all the latest news*
